These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 18946343

  • 21. T-helper and T-cytotoxic cell subsets monitoring during active cytomegalovirus infection in liver transplantation.
    Wang YL, Zhang YY, Zhou YL, Zhu ZJ, Tang ZQ, Jiang Y, Peng L, Li G, Zhang XH.
    Transplant Proc; 2004 Jun; 36(5):1498-9. PubMed ID: 15251369
    [Abstract] [Full Text] [Related]

  • 22. TH1/TH2 cytokine release pattern during in vivo cytomegalovirus disease in solid organ transplantation.
    Cervera C, Filella X, Linares L, Pineda M, Esteva C, Antón A, Marcos MA, Cofán F, Navasa M, Pérez-Villa F, Pumarola T, Moreno A.
    Transplant Proc; 2007 Sep; 39(7):2233-5. PubMed ID: 17889148
    [Abstract] [Full Text] [Related]

  • 23. Pharmacodynamic monitoring by residual NFAT-regulated gene expression in stable pediatric liver transplant recipients.
    Billing H, Breil T, Schmidt J, Tönshoff B, Schmitt CP, Giese T, Engelmann G.
    Pediatr Transplant; 2012 Mar; 16(2):187-94. PubMed ID: 22360403
    [Abstract] [Full Text] [Related]

  • 24. Cytomegalovirus infection in transplant recipients resolves when circulating gammadelta T lymphocytes expand, suggesting a protective antiviral role.
    Lafarge X, Merville P, Cazin MC, Bergé F, Potaux L, Moreau JF, Déchanet-Merville J.
    J Infect Dis; 2001 Sep 01; 184(5):533-41. PubMed ID: 11494158
    [Abstract] [Full Text] [Related]

  • 25. Subclinical inflammation in renal transplant recipients: impact of cyclosporine microemulsion versus tacrolimus.
    Lauzurica R, Pastor MC, Bayes B, Malumbres S, Homs M, Llopis MA, Bonet J, Romero R.
    Transplant Proc; 2007 Sep 01; 39(7):2170-2. PubMed ID: 17889127
    [Abstract] [Full Text] [Related]

  • 26. Serial monitoring of immunological parameters following human hand transplant.
    Zheng XF, Pei GX, Qiu YR, Zhu LJ, Gu LQ.
    Clin Transplant; 2004 Apr 01; 18(2):119-23. PubMed ID: 15016123
    [Abstract] [Full Text] [Related]

  • 27. Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor.
    Fietze E, Prösch S, Reinke P, Stein J, Döcke WD, Staffa G, Löning S, Devaux S, Emmrich F, von Baehr R.
    Transplantation; 1994 Sep 27; 58(6):675-80. PubMed ID: 7940686
    [Abstract] [Full Text] [Related]

  • 28. Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation.
    Ganepola S, Gentilini C, Hilbers U, Lange T, Rieger K, Hofmann J, Maier M, Liebert UG, Niederwieser D, Engelmann E, Heilbronn R, Thiel E, Uharek L.
    Bone Marrow Transplant; 2007 Mar 27; 39(5):293-9. PubMed ID: 17262060
    [Abstract] [Full Text] [Related]

  • 29. Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients.
    Chiereghin A, Gabrielli L, Zanfi C, Petrisli E, Lauro A, Piccirilli G, Baccolini F, Dazzi A, Cescon M, Morelli MC, Pinna AD, Landini MP, Lazzarotto T.
    Transplant Proc; 2010 Mar 27; 42(1):69-73. PubMed ID: 20172283
    [Abstract] [Full Text] [Related]

  • 30. Impact of the complement lectin pathway on cytomegalovirus disease early after kidney transplantation.
    Sagedal S, Thiel S, Hansen TK, Mollnes TE, Rollag H, Hartmann A.
    Nephrol Dial Transplant; 2008 Dec 27; 23(12):4054-60. PubMed ID: 18577532
    [Abstract] [Full Text] [Related]

  • 31. Cytomegalovirus infection in simultaneous pancreas-kidney transplantation.
    Malaise J, Ricart MJ, Moreno A, Crespo M, Fernández-Cruz L, Van Ophem D, Squifflet JP, EUROSPK Study Group.
    Transplant Proc; 2005 Dec 27; 37(6):2848-50. PubMed ID: 16182830
    [Abstract] [Full Text] [Related]

  • 32. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
    Gratama JW, Brooimans RA, van der Holt B, Sintnicolaas K, van Doornum G, Niesters HG, Löwenberg B, Cornelissen JJ.
    Cytometry B Clin Cytom; 2008 Jul 27; 74(4):211-20. PubMed ID: 18454493
    [Abstract] [Full Text] [Related]

  • 33. Oral ulcers during the course of cytomegalovirus infection in renal transplant recipients.
    López-Pintor RM, Hernández G, de Arriba L, Morales JM, Jiménez C, de Andrés A.
    Transplant Proc; 2009 Jul 27; 41(6):2419-21. PubMed ID: 19715938
    [Abstract] [Full Text] [Related]

  • 34. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation.
    Sarmiento E, Lanio N, Gallego A, Rodriguez-Molina J, Navarro J, Fernandez-Yañez J, Palomo J, Rodríguez-Hernández C, Ruiz M, Alonso R, Fernandez-Cruz E, Carbone J.
    Int Immunopharmacol; 2009 Jun 27; 9(6):649-52. PubMed ID: 18940269
    [Abstract] [Full Text] [Related]

  • 35. The novel calcineurin inhibitor ISA247: a more potent immunosuppressant than cyclosporine in vitro.
    Bîrsan T, Dambrin C, Freitag DG, Yatscoff RW, Morris RE.
    Transpl Int; 2005 May 27; 17(12):767-71. PubMed ID: 15827754
    [Abstract] [Full Text] [Related]

  • 36. Discontinuation of calcineurin inhibitors treatment allows the development of FOXP3+ regulatory T-cells in patients after kidney transplantation.
    van de Wetering J, Koumoutsakos P, Peeters A, van der Mast BJ, de Kuiper P, IJzermans JN, Weimar W, Baan CC.
    Clin Transplant; 2011 May 27; 25(1):40-6. PubMed ID: 20636406
    [Abstract] [Full Text] [Related]

  • 37. Cytomegalovirus infection in renal transplant recipients.
    Carstens J, Andersen HK, Spencer E, Madsen M.
    Transpl Infect Dis; 2006 Dec 27; 8(4):203-12. PubMed ID: 17116133
    [Abstract] [Full Text] [Related]

  • 38. Increased levels of tumor necrosis factor alpha are associated with an increased risk of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
    Reddy V, Meier-Kriesche HU, Greene S, Schold JD, Wingard JR.
    Biol Blood Marrow Transplant; 2005 Sep 27; 11(9):698-705. PubMed ID: 16125640
    [Abstract] [Full Text] [Related]

  • 39. Immunologic parameters as predictive factors of cytomegalovirus disease in renal allograft recipients.
    Nordøy I, Müller F, Nordal KP, Rollag H, Lien E, Aukrust P, Frøland SS.
    J Infect Dis; 1999 Jul 27; 180(1):195-8. PubMed ID: 10353879
    [Abstract] [Full Text] [Related]

  • 40. Diagnostic value of T-cell monitoring assays in kidney transplantation.
    Nickel P, Bestard O, Volk HD, Reinke P.
    Curr Opin Organ Transplant; 2009 Aug 27; 14(4):426-31. PubMed ID: 19417657
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.